Bessemer Group Inc. cut its position in shares of CME Group Inc. (NASDAQ:CME) by 65.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,293 shares of the financial services provider’s stock after selling 8,267 shares during the quarter. Bessemer Group Inc.’s holdings in CME Group were worth $583,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Janus Henderson Group PLC boosted its stake in CME Group by 13,530.7% in the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock valued at $770,227,000 after acquiring an additional 6,104,897 shares during the last quarter. Fiera Capital Corp boosted its stake in CME Group by 243.9% in the second quarter. Fiera Capital Corp now owns 1,926,918 shares of the financial services provider’s stock valued at $241,327,000 after acquiring an additional 1,366,557 shares during the last quarter. Wells Fargo & Company MN boosted its stake in CME Group by 25.5% in the second quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock valued at $548,496,000 after acquiring an additional 889,217 shares during the last quarter. BT Investment Management Ltd purchased a new position in CME Group in the second quarter valued at about $95,104,000. Finally, Pioneer Investment Management Inc. boosted its stake in CME Group by 1,359.5% in the second quarter. Pioneer Investment Management Inc. now owns 697,380 shares of the financial services provider’s stock valued at $87,340,000 after acquiring an additional 649,599 shares during the last quarter. Hedge funds and other institutional investors own 82.63% of the company’s stock.

WARNING: “Bessemer Group Inc. Has $583,000 Position in CME Group Inc. (CME)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this story can be read at https://www.thecerbatgem.com/2017/11/18/bessemer-group-inc-has-583000-position-in-cme-group-inc-cme.html.

In other news, Director Daniel R. Glickman sold 850 shares of the company’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $126.65, for a total value of $107,652.50. Following the completion of the sale, the director now owns 13,799 shares of the company’s stock, valued at approximately $1,747,643.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John W. Pietrowicz sold 5,175 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The disclosure for this sale can be found here. Insiders sold a total of 11,339 shares of company stock worth $1,548,086 in the last three months. Insiders own 0.57% of the company’s stock.

CME Group Inc. (NASDAQ:CME) opened at $139.49 on Friday. The company has a market cap of $47,680.00, a price-to-earnings ratio of 29.33, a PEG ratio of 2.88 and a beta of 0.71. CME Group Inc. has a twelve month low of $111.19 and a twelve month high of $141.44. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.05 EPS. equities research analysts expect that CME Group Inc. will post 4.78 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date is Thursday, December 7th. CME Group’s payout ratio is 59.86%.

A number of research analysts have weighed in on the stock. BidaskClub cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $127.00 target price on shares of CME Group in a research note on Friday, August 18th. Citigroup Inc. boosted their target price on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Royal Bank Of Canada set a $135.00 target price on shares of CME Group and gave the company a “buy” rating in a research note on Tuesday, August 1st. Finally, UBS AG reiterated a “buy” rating and issued a $135.00 target price (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. One analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and a consensus target price of $141.75.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.